NIH-funded research NIH-funded research

Using mRNA gene therapy to find a cure for HIV

Official title: A multipronged, mRNA gene therapy approach to HIV cure

Funded at University of Pennsylvania · NIH-10948500 · Data updated 2026-11-12

This study is exploring a new way to help people with HIV by using mRNA therapy to wake up the hidden virus and help the body get rid of it, making treatment easier and more effective.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJune 6, 2025
Project endMay 31, 2030
Funding year2025
Award (this year)$486,057
NIH project number1DP2AI184637-01
Project IDNIH-10948500 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who have not responded adequately to current antiretroviral therapies.

Less likely to help

Patients who are not infected with HIV or those who have advanced AIDS may not benefit from this research.

What this research studies

This research investigates a novel approach to curing HIV by utilizing mRNA gene therapy. It aims to address the challenges of HIV latency, where the virus hides from the immune system, by combining strategies to reactivate the virus and eliminate it. The therapy involves delivering mRNA that encodes specific genes in lipid nanoparticles, which can be engineered to target particular immune cells. This method is designed to be efficient, cost-effective, and flexible, potentially overcoming previous limitations in HIV treatment.

Why it matters

Potential benefit: If successful, this research could lead to a functional cure for HIV, significantly improving the quality of life for patients living with the virus.

How similar studies have gone: While there have been promising advancements in HIV treatment, this specific approach using mRNA gene therapy is relatively novel and has not been extensively tested in this context.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Kreider, Edward — University of Pennsylvania
  • Study coordinator: Kreider, Edward

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.